Metrics
Publication
56
Open Access
11
UN Sustainable Development Goals
Education
2012 - 2016
2012 - 2016Post Doctorate
Hacettepe University, Çocuk Sağlığı Enstitüsü, Pediatrik İmmünoloji Bilim Dalı, Turkey
2008 - 2012
2008 - 2012Doctorate
Hacettepe University, Onkoloji Enstitüsü, Turkey
Dissertations
2012
2012Doctorate
MEME KANSERİNDE FOXP1'İN PI3K/AKT SİNYAL YOLAĞI TARAFINDAN DÜZENLENMESİ
Hacettepe Üniversitesi, Onkoloji Enstitüsü, Tümör Biyolojisi Ve İmmünolojisi
2008
2008Postgraduate
P53-/- ve P53 +/+ HCT116 KOLON KANSER HÜCRE SERİLERĐNDE RADYASYONUN HÜCRE
PROLİFERASYONU VE TELOMERAZ AKTİVĐTESİ ÜZERİNE ETKİSİ 
Ankara Üniversitesi, Biyoteknoloji Enstitüsü, Temel Biyoteknoloji
Foreign Languages
C1 Advanced
C1 AdvancedEnglish
Certificates, Courses and Trainings
2019
20196. Turkish-US Cytometry Workshop
Health&Medicine
İstanbul Üniversitesi
Research Areas
Medicine
Health Sciences
Fundamental Medical Sciences
Medical Biology
Life Sciences
Molecular Biology and Genetics
Genetic Disorders
Natural Sciences
Research Areas Based on Academic Activities
Avesis Research Areas
WoS Research Areas
Scopus Research Areas
Academic Positions
2024 - Present
2024 - PresentAssociate Professor
Hacettepe University, Çocuk Sağlığı Enstitüsü, Pediatrik Temel Bilimler A.B.D.
2022 - 2024
2022 - 2024Assistant Professor
Hacettepe University, Çocuk Sağlığı Enstitüsü
2018 - 2022
2018 - 2022Lecturer PhD
Hacettepe University, Çocuk Sağlığı Enstitüsü, Pediatrik İmmünoloji Bilim Dalı
2017 - 2018
2017 - 2018Researcher
Hacettepe University, Çocuk Sağlığı Enstitüsü
2016 - 2017
2016 - 2017Researcher
University of London-Kings College London, Faculty of Life Sciences and Medicine
2012 - 2016
2012 - 2016Occupational Expert
Hacettepe University, Çocuk Sağlığı Enstitüsü, Pediatrik Temel Bilimler A.B.D.
2009 - 2012
2009 - 2012Research Assistant
Hacettepe University, Kanser Enstitüsü, Temel Onkoloji A.B.D.
2009 - 2009
2009 - 2009Researcher
University of Oxford, Nuffield Department of Laboratory Sciences
Articles
All (37)
SCI-E, SSCI, AHCI (29)
SCI-E, SSCI, AHCI, ESCI (36)
ESCI (5)
Scopus (36)
TRDizin (8)
2025
20251. Endoplasmic reticulum stress pathways and cellular death mechanisms in patients with phenylketonuria
Gurses Cila H. E., DURSUN A., Vardar Acar N., Gecici N. N., AYHAN S., OSKAY HALAÇLI S., et al.
MOLECULAR BIOLOGY REPORTS
, vol.52, no.1, 2025 (SCI-Expanded, Scopus)
2025
20252. Beyond the Classical Triad: Atypical Presentations and Regulatory T Cell Phenotyping in a Cohort of IPEX Patients
Yaz İ., Oskay Halacli S., Ipsir C., Ulum B., Soyak Aytekin E., Bildik H. N., et al.
JOURNAL OF CLINICAL IMMUNOLOGY
, vol.45, no.1, 2025 (SCI-Expanded, Scopus)
2025
20253. Sequential assessment of septic patients for immune profiling: A focus on persistent inflammation, immunosuppression, and catabolism syndrome.
Halacli B., Yilmaz K., Kara R., Bolat A. B., Topeli A., Tezcan I., et al.
Journal of critical care
, vol.89, pp.155158, 2025 (SCI-Expanded, Scopus)
2025
20254. Arachidonoylcyclopropylamide (ACPA) reduces viability and induces endoplasmic reticulum stress in glioma cells
Karakoc E., Türeli M. A., HANELCİ R. H., ERSOY Ü., halacli s. o., ATILLA P.
Türk Hijyen ve Deneysel Biyoloji Dergisi
, vol.82, no.3, pp.419-426, 2025 (Scopus, TRDizin)
2025
20255. Change in Gasdermin-D gene expression in familial Mediterranean fever compared to healthy children with or without acute infections
Avar Aydın P. Ö., Yaz İ., İnan D., Özçakar Z. B., Oskay Halaçlı S., Çağdaş Ayvaz D. N.
TURKISH JOURNAL OF PEDIATRICS
, vol.67, no.3, pp.361-371, 2025 (SCI-Expanded, Scopus, TRDizin)
2025
20256. Regulatory T Cell Sub-Populations in Patients with Distinct Autoimmune/Inflammatory Diseases With or Without Inborn Errors of Immunity
Oskay Halacli S., Inan D., Esenboga S., Bildik H. N., Bolat A. B., Tezcan I., et al.
DIAGNOSTICS
, vol.15, no.15, pp.1-5, 2025 (SCI-Expanded, Scopus)
2025
20257. N-acetylcysteine stimulates organelle malfunction in endometriotic cells via IFN-gamma signaling
KARAKOÇ E., OSKAY HALAÇLI S., HANELCI R. H., AYHAN S., EYLEM C. C., NEMUTLU E., et al.
SCIENTIFIC REPORTS
, no.1, 2025 (SCI-Expanded, Scopus)
2024
20248. Comparative analysis of protein expression profiles with genotypes in the diagnosis of Inborn Errors of Immunity.
Oskay Halacli S., Cagdas D. N., Esenboga S., Inan D., Yaz İ., Cicek B., et al.
Scandinavian journal of clinical and laboratory investigation
, pp.1-10, 2024 (SCI-Expanded, Scopus)
2024
20249. A single center experience on PI3K/AKT/MTOR signaling defects: Towards pathogenicity assessment for four novel defects.
Bildik H. N., Esenboga S., Halaclı S., Karaatmaca B., Aytekin E. S., Nabiyeva N., et al.
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
, vol.35, no.9, 2024 (SCI-Expanded, Scopus)
2024
202410. Investigation of the Hepatitis-B Vaccine's Immune Response in a Non-Alcoholic Fatty Liver Disease Mouse Model
Kutuk T., ONBAŞILAR İ., Oskay-Halacli S., BABAOĞLU B., AYHAN S., YALÇIN S. S.
VACCINES
, vol.12, no.8, 2024 (SCI-Expanded, Scopus)
2024
202411. False Negative Next-Generation-Sequencing Analysis in a Lipopolysa ccharide-Responsive Beige-Like Anchor Defect.
Ünal T., Esenboğa S., Oskay Halaçlı S., Tezcan I., Çağdaş D. N.
Turkish archives of pediatrics
, vol.59, no.2, pp.221-223, 2024 (ESCI, TRDizin)
2023
202312. A Novel Interleukin 17 Receptor A Mutation in a Child with Chronic Mucocutaneous Candidiasis and Staphylococcal Skin Infections
Yakici N., , Oskay Halacli S., Tan C., Gur Cetinkaya P., Akar H. T., et al.
TURK PEDIATRI ARSIVI
, vol.1, no.1, pp.1-3, 2023 (Scopus)
2022
202213. Mutation in BTK Gene Causing an Atypical Presentation of XLA
Esenboğa S., Ucler H., Oskay Halaclı S., Tan C., Kendırcı N., Zhang Y., et al.
ASTIM ALLERJI IMMUNOLOJI
, vol.20, no.3, pp.197-201, 2022 (Scopus, TRDizin)
2022
202214. A single-center study points to diverse features and outcome in patients with Hyperimmunoglobulin M Syndrome and Class- Switch Recombination defects
Akarsu A., Halaçlı S., Tan Ç., Kuşkonmaz B. B., Küpesiz A., Çetinkaya D., et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY
, vol.96, no.5, 2022 (SCI-Expanded, Scopus)
2022
202215. Clinical, Laboratory Features and Clinical Courses of Patients with Wiskott Aldrich Syndrome and X-linked Thrombocytopenia-A single center study.
Bildik H. N., Cagdas D. N., Ozturk Kura A., Oskay Halacli S., Sanal O., Tezcan I.
Immunological investigations
, vol.51, no.5, pp.1272-1283, 2022 (SCI-Expanded, Scopus)
2022
202216. The effect of mutatio-type on proteo-phenotype and clinico-phenotype in selected primary immunodeficiencies.
Halacli S.
Immunologic research
, vol.70, no.1, pp.56-66, 2022 (SCI-Expanded, Scopus)
2021
202117. Diversity in Serine/Threonine Protein Kinase-4 Deficiency and Review of the Literature
Cagdas D. N., Halacli S., Tan C., Esenboğa S., Karaatmaca B., Cetinkaya P. G., et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE
, vol.9, no.10, pp.3752-3770, 2021 (SCI-Expanded, Scopus)
2021
202118. Clinical and laboratory findings in patients with leukocyte adhesion deficiency type I: A multicenter study in Turkey
Yaz İ., Ozbek B., Bildik H. N., Tan C., Oskay Halacli S., Soyak Aytekin E., et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY
, vol.206, no.1, pp.47-55, 2021 (SCI-Expanded, Scopus)
2021
202119. The imbalance of the circulating regulatory B cell subsets in patients with primary immunodeficiencies
Halacli S., Inan D., BİLDİK H. N., AKARSU A., Kahveci M., Ozbek B., et al.
EUROPEAN JOURNAL OF IMMUNOLOGY
, vol.51, pp.83, 2021 (SCI-Expanded, Scopus)
2021
202120. Clinical and Immunological Characteristics of 63 Patients with Chronic Granulomatous Disease: Hacettepe Experience
Akar H. T., Esenboga S., Cagdas D. N., Halacli S., Ozbek B., van Leeuwen K., et al.
JOURNAL OF CLINICAL IMMUNOLOGY
, vol.41, no.5, pp.992-1003, 2021 (SCI-Expanded, Scopus)
2021
202121. Flow Cytometric Analysis of T Cell V beta Repertoire in Common Variable Immunodeficiency Patients with TACI Mutations
OSKAY HALAÇLI S., ÖZBEK B., Aytekin E. S., YAZ İ., TAN Ç., ÇAĞDAŞ AYVAZ D. N., et al.
TURKISH JOURNAL OF IMMUNOLOGY
, vol.9, no.1, pp.12-19, 2021 (ESCI, Scopus)
2021
202122. Flow Cytometric Analysis of T Cell Vβ Repertoire in Common Variable Immunodeficiency Patients with TACI Mutations
OSKAY HALAÇLI S., ÖZBEK B., SOYAK AYTEKİN E., YAZ İ., TAN Ç., ÇAĞDAŞ AYVAZ D. N., et al.
TURKISH JOURNAL OF IMMUNOLOGY
, vol.9, no.1, pp.12-19, 2021 (ESCI, Scopus, TRDizin)
2020
202023. Lymphocyte Subgroups and KREC Numbers in Common Variable Immunodeficiency: A Single Center Study
Yaz I., Ozbek B., Ng Y. Y., Cetinkaya P. G., Halacli S., TAN Ç., et al.
JOURNAL OF CLINICAL IMMUNOLOGY
, vol.40, no.3, pp.494-502, 2020 (SCI-Expanded, Scopus)
2020
202024. Flow Cytometry is a Reliable Tool in the Diagnosis of STK4 Deficiency
Oskay Halaçlı S., Çağdaş Ayvaz D. N., Tezcan F. İ.
ASTIM ALLERJI IMMUNOLOJI
, vol.18, pp.113-117, 2020 (ESCI, TRDizin)
2019
201925. A Spectrum of Clinical Findings from ALPS to CVID: Several Novel LRBA Defects
Cagdas D. N., Halaçlı S., Tan Ç., Lo B., Çetinkaya P., Esenboğa S., et al.
JOURNAL OF CLINICAL IMMUNOLOGY
, vol.39, no.7, pp.726-738, 2019 (SCI-Expanded, Scopus)
2019
201926. The significance of Western Blot in Primary Immunodeficiencies: Examples from two families
Halacli S., Cagdas D. N., TEZCAN F. İ.
TURKISH JOURNAL OF IMMUNOLOGY
, vol.7, no.3, pp.120-124, 2019 (ESCI, Scopus, TRDizin)
2018
201827. Expression of ADAMTS2 and ADAMTS5 in the salivary gland of rats after radioiodine therapy
Sadic M., Demirel K., OSKAY HALAÇLI S., Karakok E., Koca G., Ekinci O., et al.
NUCLEAR MEDICINE COMMUNICATIONS
, vol.39, no.2, pp.110-117, 2018 (SCI-Expanded, Scopus)
2017
201728. PAK5 mediates cell: cell adhesion integrity via interaction with E-cadherin in bladder cancer cells.
Ismail A., Oskay H., Babteen N., De P., Martin T., Jiang W., et al.
The Biochemical journal
, vol.474, pp.1333-1346, 2017 (SCI-Expanded, Scopus)
2017
201729. FOXP1 enhances tumor cell migration by repression of NFAT1 transcriptional activity in MDA-MB-231 cells
Halacli S.
CELL BIOLOGY INTERNATIONAL
, vol.41, no.1, pp.102-110, 2017 (SCI-Expanded, Scopus)
2016
201630. Investigation of hemophagocytic lymphohistiocytosis in severe sepsis patients.
HALACLI B., Unver N., HALACLI S., CANPINAR H., ERSOY E., OCAL S., et al.
Journal of critical care
, vol.35, pp.185-90, 2016 (SCI-Expanded, Scopus)
2015
201531. STK4 (MST1) deficiency in two siblings with autoimmune cytopenias: A novel mutation
HALACLI S. O., AYVAZ D. N., Sun-Tan C., Erman B., Uz E., YILMAZ D. Y., et al.
CLINICAL IMMUNOLOGY
, vol.161, no.2, pp.316-323, 2015 (SCI-Expanded, Scopus)
2015
201532. Interleukin-1β induced nuclear factor-κB binds to a disintegrin-like and metalloproteinase with thrombospondin type 1 motif 9 promoter in human chondrosarcoma cells.
Altuntas A., Halacli S., Cakmak O., Erden G., Akyol S., Ugurcu V., et al.
Molecular medicine reports
, vol.12, pp.595-600, 2015 (SCI-Expanded, Scopus)
2015
201533. FOXP1 regulation via the PI3K/Akt/p70S6K signaling pathway in breast cancer cells
Halacli S., DOĞAN A. L.
ONCOLOGY LETTERS
, vol.9, no.3, pp.1482-1488, 2015 (SCI-Expanded, Scopus)
2013
201334. Effects of gamma irradiation on cell cycle, apoptosis and telomerase activity in p53 wild-type and deficient HCT116 colon cancer cell lines.
Halacli S., Canpinar H., Cimen E., Sunguroglu A.
Oncology letters
, vol.6, pp.807-810, 2013 (SCI-Expanded, Scopus)
2013
201335. The significance of heat shock proteins in breast cancer therapy
OSKAY HALAÇLI S., HALAÇLI B., Altundag K.
MEDICAL ONCOLOGY
, vol.30, no.2, 2013 (SCI-Expanded, Scopus)
2012
201236. Regulation of HIF-1 alpha Expression By PI3K/Akt Pathway Inhibitors in Breast Cancer Cell Lines
DOĞAN A. L., Cimen E., Oskay S., Oksuz S., Guc D.
TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI
, vol.37, no.3, pp.264-271, 2012 (SCI-Expanded, Scopus, TRDizin)
2009
200937. CONSTRUCTION OF BICISTRONIC B-GALACTOSIDASE REPORTER PLASMIDS FOR EUKARYOTIC EXPRESSION OF CD40 LIGAND (CD40L) GENE
Dolen Y., ESENDAĞLI G., Oskay S., Guc D.
IUBMB LIFE
, vol.61, no.3, pp.335, 2009 (SCI-Expanded, Scopus)
Papers Presented at Peer-Reviewed Scientific Conferences
2024
20241. IPEX Sendromu Tek Merkez Deneyimi
YAZ İ., OSKAY HALAÇLI S., İPŞİR C., ULUM B., ESENBOĞA S., BİLDİK H. N., et al.
XXX. ULUSLARARASI KATILIMLI ULUSAL ALLERJİ KLİNİK İMMÜNOLOJİ KONGRESİ, Antalya, Turkey, 27 November - 01 December 2024, (Summary Text)
2024
20242. Inflammatory parameters and innate lymphoid cells in chilhood interstitial lung diseases: a prospective study
Hizal M., Oskay Halaçlı S., Nayır-Büyükşahin H, H., Çiftçier B., Yılmaz K., Emiralioglu Ordukaya N., et al.
ERS Congress 2024 abstracts, 14 September 2024, pp.1, (Full Text)
2021
20213. Primer İmmün Yetmezlik Şüpheli Hastalarda DOCK8 Protein İfadesinin İncelenmesi
İnan D., OSKAY HALAÇLI S., YAZ İ., ESENBOĞA S., ÇAĞDAŞ AYVAZ D. N., TEZCAN F. İ.
7. klinik İmmünoloji Kongresi, Turkey, 6 - 09 October 2021, vol.1, pp.90, (Summary Text)
2020
20204. LÖKOSİT ADEZYON DEFEKTİ TANISI ALAN HASTALARIN KLİNİK VE LABORATUVAR BULGULARININ DEĞERLENDİRİLMESİ
YAZ İ., ÖZBEK B., TAN Ç., BİLDİK H. N., OSKAY HALAÇLI S., SOYAK AYTEKİN E., et al.
6. KLİNİK İMMÜNOLOJİ KONGRESİ, Turkey, 31 October - 01 November 2020, (Summary Text)
2020
20205. CTLA-4 Eksikliği Saptanan Hastaların Klinik Fenotipik, Laboratuvar Bulguları ile Tedavi Yanıtının Değerlendirilmesi
SOYAK AYTEKİN E., TAN Ç., OSKAY HALAÇLI S., BİLDİK H. N., ÇİÇEK B., YAZ İ., et al.
6. KLİNİK İMMÜNOLOJİ KONGRESİ, Turkey, 31 October - 01 November 2020, (Summary Text)
2020
20206. HACETTEPE ÜNİVERSİTESİ ÇOCUK İMMÜNOLOJİ BÖLÜMÜNDE SON BEŞ YILDA İZLENEN HASTALARIN DAĞILIMLARI
KOÇALİ B., SOYAK AYTEKİN E., ÇAĞDAŞ AYVAZ D. N., GÜR ÇETİNKAYA P., ESENBOĞA S., KARAATMACA B., et al.
6. KLİNİK İMMÜNOLOJİ KONGRESİ, Turkey, 31 October - 01 November 2020, (Full Text)
2020
20207. STAT1 MUTASYONU SAPTANAN 11 HASTANIN KLİNİK, GENETİK VE FENOTİPİK BULGULARININ DEĞERLENDİRİLMESİ
SOYAK AYTEKİN E., YAZ İ., ÖZBEK B., OSKAY HALAÇLI S., TAN Ç., BARIŞ S., et al.
6. KLİNİK İMMÜNOLOJİ KONGRESİ, Turkey, 31 October - 01 November 2020, (Summary Text)
2020
20208. Kronik Granülomatöz Hastalık Tanısı Alan Hastaların Yeni Nesil Dizileme Teknolojisi İle Analizi
ÖZBEK B., YAZ İ., TAN Ç., SOYAK AYTEKİN E., OSKAY HALAÇLI S., BİLDİK H. N., et al.
6. KLİNİK İMMÜNOLOJİ KONGRESİ, Turkey, 31 October - 01 November 2020, (Summary Text)
2020
20209. Primer İmmün Yetmezliklerde CFSE Hücre Proliferasyon Analizi: Referans Değerler
OSKAY HALAÇLI S., SOYAK AYTEKİN E., BİLDİK H. N., OCAK M., ÇAĞDAŞ AYVAZ D. N., TEZCAN F. İ.
6. Klinik İmmünoloji Kongresi, Online, 31 October - 01 November 2020, pp.119-120, (Summary Text)
2020
202010. HOMOZİGOT VE HETEROZİGOT TACI MUTASYONU SAPTANAN PİY'Lİ HASTALARIN KLİNİK VE İMMÜNOLOJİK BULGULARININ DEĞERLENDİRİLMESİ
ÖZBEK B., YAZ İ., TAN Ç., OSKAY HALAÇLI S., SOYAK AYTEKİN E., BİLDİK H. N., et al.
6. KLİNİK İMMÜNOLOJİ KONGRESİ, Turkey, 31 October - 01 November 2020, (Full Text)
2019
201911. TACI Defekti Saptanan Primer İmmün Yetmezlikli Hastaların Klinik ve İmmünolojik Parametrelerinin Değerlendirilmesi
ÖZBEK B., TAN Ç., SOYAK AYTEKİN E., OSKAY HALAÇLI S., YAZ İ., SÖNMEZ M., et al.
5. KLİNİK İMMÜNOLOJİ KONGRESİ, Turkey, 20 - 23 March 2019, (Summary Text)
2019
201912. TACI defekti saptanan yaygın değişken immün yetmezlikli hastalarda TCRVB repertuvarının değerlendirilmes
OSKAY HALAÇLI S., ÖZBEK B., SOYAK AYTEKİN E., YAZ İ., KARAPINAR Ö., ÇAĞDAŞ AYVAZ D. N., et al.
5. KLİNİK İMMÜNOLOJİ KONGRESİ, Turkey, 20 - 23 March 2019, (Summary Text)
2016
201613. Lipopolisakkarit e duyarlı beige benzeri Protein LRBA Defekti Bulunan Hastaların Klinik ve Laboratuvar Bulgularının Değerlendirilmesi Hacettepe Serisi
ÇAĞDAŞ AYVAZ D. N., KARAATMACA B., ESENBOĞA S., YILMAZ T., ERMAN B., TAN Ç., et al.
2. Klinik İmmünoloji Kongresi, Turkey, 31 March - 03 April 2016, (Full Text)
2015
201514. STK 4 MST1 Deficiency in Three Families with the Clinical and Immunological Features of AR HIES
ÇAĞDAŞ AYVAZ D. N., oskay S., TAN Ç., Erman B., UZ E., ÖZGÜL R. K., et al.
International Forum on Immunology Research, 8 - 10 October 2015, (Full Text)
2014
201415. CLINICAL AND IMMUNOLOGIC FEATURES OF PATIENTS WITH THE PHENOTYPE OF AR-HIES: PATIENTS WITH AND WITHOUT DOCK8 DEFICIENCY
Sanal O., Ayvaz D. N., TAN Ç., Oskay S., Uz E., Akarsu N., et al.
100th J Project Meeting, Antalya, Turkey, 12 - 14 March 2014, vol.34, pp.746-747, (Summary Text)
Books
2022
20221. KATKI-Immunolojı I ve II
ÇAĞDAŞ AYVAZ D. N., TEZCAN F. İ., ESENBOĞA S., Bayak Ş., KOÇALİ B., AKARSU A., et al.
Alp Ofset ve Matbaacılık Makin Sanayi ve Ticaret Limited Şirketi, Ankara, 2022
2021
20212. Flow Cytometric Approach in the Diagnosis of Primary Immunodeficiencies
Oskay Halaçlı S.
in: Cell Interaction-Regulation of Immune Responses, Disease Development and Management Strategies, Bhawana Singh, Editor, intechopen, London, pp.1-21, 2021
Funded Projects
2023 - 2025
2023 - 2025Hiperimmünglobulin E Sendromu Tanılı hastalarda immünfenotipik değerlendirmeye ek olarak lenfoid hucre ve nötrofillerde retinoik asit ve anti-IL23 uyarımı ile ilişkili gen ekspresyon analizi
TUBITAK Project , 1001 - Program for Supporting Scientific and Technological Research Projects
Çağdaş Ayvaz D. N.(Executive), Peynircioğlu B., Kelicen Uğur E. P., Akkaya Ulum Z. Y., Esenboğa S., Oskay Halaçli S., et al.
2018 - 2023
2018 - 2023Kombine İmmün Yetmezlik Tanısı Alan Hasta Grubunda Regülatuvar T ve B Hücre Alt Gruplarının Araştırılması
Project Supported by Higher Education Institutions , BAP Research Project
OSKAY HALAÇLI S. (Executive), AERTS KAYA F. S. F., ÇAĞDAŞ AYVAZ D. N., TEZCAN F. İ.
Peer Reviews in Scientific Publications
January 2018
January 2018ONCOLOGY LETTERS
Journal Indexed in SCI-E
January 2018
January 2018ONCOLOGY REPORTS
Journal Indexed in SCI-E
January 2015
January 2015TUMOR BIOLOGY
Journal Indexed in SCI-E
Scientific Project Refereeing
February 2020
February 2020TUBITAK Project
1001 - Program for Supporting Scientific and Technological Research Projects, Hacettepe University, Turkey
Scholarships
2016 - 2017
2016 - 20172219- Yurt Dışı Doktora Sonrası Araştırma Bursu
TUBITAK
2006 - 2006
2006 - 2006